Simplex Trading’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,100
| Closed | -$37K | – | 10180 |
|
|
2025
Q3 | $37K | Sell |
1,100
-100
| -8% | -$2.87K | ﹤0.01% | 6755 |
|
|
2025
Q2 | $32K | Sell |
1,200
-200
| -14% | -$5.79K | ﹤0.01% | 6354 |
|
|
2025
Q1 | $41K | Buy |
1,400
+800
| +133% | +$30.5K | ﹤0.01% | 5985 |
|
|
2024
Q4 | $23K | Buy |
600
+300
| +100% | +$11.4K | ﹤0.01% | 6591 |
|
|
2024
Q3 | $10K | Sell |
300
-2,000
| -87% | -$56.3K | ﹤0.01% | 7213 |
|
|
2024
Q2 | $49K | Buy |
2,300
+1,400
| +156% | +$29.4K | ﹤0.01% | 6125 |
|
|
2024
Q1 | $19K | Buy |
900
+500
| +125% | +$12.2K | ﹤0.01% | 7143 |
|
|
2023
Q4 | $11K | Sell |
400
-400
| -50% | -$9.66K | ﹤0.01% | 7390 |
|
|
2023
Q3 | $17K | Buy |
800
+700
| +700% | +$18K | ﹤0.01% | 6777 |
|
|
2023
Q2 | $2K | Sell |
100
-7,000
| -99% | -$170K | ﹤0.01% | 8496 |
|
|
2023
Q1 | $158K | Sell |
7,100
-14,200
| -67% | -$343K | ﹤0.01% | 4606 |
|
|
2022
Q4 | $505K | Sell |
21,300
-14,500
| -41% | -$337K | ﹤0.01% | 3146 |
|
|
2022
Q3 | $594K | Buy |
35,800
+16,900
| +89% | +$380K | ﹤0.01% | 3265 |
|
|
2022
Q2 | $376K | Buy |
18,900
+17,900
| +1,790% | +$362K | ﹤0.01% | 3813 |
|
|
2022
Q1 | $27K | Buy |
1,000
+700
| +233% | +$20K | ﹤0.01% | 7910 |
|
|
2021
Q4 | $12K | Hold |
300
| – | – | ﹤0.01% | 8886 |
|
|
2021
Q3 | $12K | Hold |
300
| – | – | ﹤0.01% | 8842 |
|
|
2021
Q2 | $11K | Buy |
300
+295
| +5,900% | +$12.6K | ﹤0.01% | 9056 |
|
|
2021
Q1 | $26K | Hold |
5
| – | – | ﹤0.01% | 7256 |
|
|
2020
Q4 | $24K | Sell |
5
-197
| -98% | -$9.13K | ﹤0.01% | 6858 |
|
|
2020
Q3 | $656K | Buy |
202
+2
| +1% | +$64 | ﹤0.01% | 2716 |
|
|
2020
Q2 | $518K | Sell |
200
-91
| -31% | -$2.27K | ﹤0.01% | 2861 |
|
|
2020
Q1 | $707K | Sell |
291
-26
| -8% | -$654 | ﹤0.01% | 2234 |
|
|
2019
Q4 | $885K | Buy |
317
+314
| +10,467% | +$8.13K | ﹤0.01% | 2198 |
|
|
2019
Q3 | $7K | Sell |
3
-137
| -98% | -$3.64K | ﹤0.01% | 6465 |
|
|
2019
Q2 | $399K | Sell |
140
-227
| -62% | -$5.67K | ﹤0.01% | 2797 |
|
|
2019
Q1 | $918K | Buy |
+367
| New | +$7.01K | ﹤0.01% | 2070 |
|
|
2018
Q4 | – | Sell |
-346
| Closed | -$330K | – | 7882 |
|
|
2018
Q3 | $330K | Sell |
346
-118
| -25% | -$1.3K | ﹤0.01% | 3060 |
|
|
2018
Q2 | $433K | Buy |
+464
| New | +$3.26K | ﹤0.01% | 2611 |
|
Other funds holding VCYT
VPM
VCM
AIM
Simplex Trading's VCYT Position: Q1 2026 in Review
Simplex Trading increased its Veracyte (VCYT) stake by 2,574% in Q1 2026, buying an estimated $32.4K and bringing the position to 909 shares worth $29.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6412.
Simplex Trading first reported a position in VCYT in Q1 2016 and has held it in 31 quarters since. The position peaked at $462K in Q4 2016. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.
- Simplex Trading held 909 shares of Veracyte worth $29.3K as of Q1 2026.
- Simplex Trading bought 875 Veracyte shares in Q1 2026, an estimated $32.4K.
- Veracyte made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6412 holding.
- Simplex Trading first reported a position in Veracyte in Q1 2016 and has held it in 31 quarters since.
- Simplex Trading's Veracyte position peaked at $462K in Q4 2016.
- 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.